Connect your AI

Sabra Healthcare SBRA Proceeds From Repayments Of Lines Of Credit

Proceeds From Repayments Of Lines Of Credit at other companies

HCA HealthcareHCA

$1.44B+552%

VTR

VentasVTR

——

Other financials

Income statement

Revenue$221.8M+20.8%

Net income$40.9M+1.4%

EPS (diluted)$0.16-5.9%

Balance sheet

Cash & equivalents$116.5M+414%

Total debt$7.3M-9.6%

Total equity$2.8B+3.1%

Total assets$5.6B+6.8%

Cash flow

Operating cash flow$98.4M+22.5%

Valuation

Market cap$4.57B+16.7%

Profitability

Net margin19.2%-0.3pp

Returns & leverage

Return on equity5.7%+0.5pp

Debt / equity0×0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromRepaymentsOfLinesOfCredit.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's proceeds from repayments of lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sabra Healthcare's proceeds from repayments of lines of credit?: Sabra Healthcare (SBRA) reported proceeds from repayments of lines of credit of $137.8M in Q1 2026.
How has Sabra Healthcare's proceeds from repayments of lines of credit changed year-over-year?: Sabra Healthcare's proceeds from repayments of lines of credit increased by 677.0% year-over-year, from -$23.88M to $137.8M.